Tech Company Financing Transactions
Cleveland Biolabs Funding Round
Sunrise Capital and private investors participated in a $6 million funding round for Cleveland Biolabs. The financing round was announced on 3/31/2005.
Transaction Overview
Company Name
Announced On
3/31/2005
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
73 High St.
Buffalo, NY 14203
USA
Buffalo, NY 14203
USA
Phone
Website
Email Address
Overview
Clinical-stage biotech developing a robust pipeline of drugs for multiple medical and defense applications, with a focus on oncology and tissue protection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yakov Kogan
Chief Medical Officer
Langdon Miller
Chief Scientific Officer
Andrei Gudkov
Vice President
Andrei Purmal
VP - Regulatory Affairs
Ann Hards
Browse more venture capital transactions:
Prev: 3/31/2005: Project Y venture capital transaction
Next: 3/31/2005: BPL Global venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. All VC database entries on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs